XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Value investing focuses on identifying undervalued stocks for growth. Explore strategies that can help maximize your investment returns effectively.
25,836 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Anthropic's Claude Opus 4.6 launch jolts tech stocks and Bitcoin, signaling a deeper tech-cycle adjustment rather tha...
A Friday deadline intensifies a clash between Anthropic and the Pentagon over how its Claude AI models may be used by...
In 2026, a growing number of VCs weigh founders’ families and mentors as part of the investment thesis, a trend chang...
Meta unveils its MTIA 300 AI inference chip, signaling a move to in-house AI deployment that could alter ROI dynamics...
Rising college costs push families to mix aid, savings, and careful borrowing. This report breaks down how to evaluat...
Stocks rise on renewed Iran optimism even as verifiable details lag; UBS cautions that headline-driven moves can blur...
Megapot has secured $5 million in a Dragonfly-led round to scale a crypto-powered global lottery. The platform now se...
Hut 8 is pivoting to AI data center infrastructure, prompting a Canaccord upgrade that nearly doubles the firm’s pric...
Inflation is rising, yet improved mortgage spreads are keeping 30-year fixed rates below 7%. Borrowers should watch h...
Markets show crypto longer single industry dynamics fading as four distinct lanes diverge. Bitcoin, stablecoins, toke...
Pay transparency is surfacing a bigger problem: firms publish pay ranges but struggle to explain how they set actual ...